Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
4.660
-0.140 (-2.92%)
At close: Nov 20, 2024, 4:00 PM
4.770
+0.110 (2.36%)
After-hours: Nov 20, 2024, 7:57 PM EST
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $780.00 million as of November 21, 2024. Its market cap has decreased by -22.36% in one year.
Market Cap
780.00M
Enterprise Value
-9.79M
1-Year Change
-22.36%
Ranking
Category
Stock Price
$4.66
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $780.00M, a decrease of -74.30%. That is a compound annual growth rate of -26.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 780.00M | -42.53% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytek Biosciences | 789.61M |
| AbCellera Biologics | 788.63M |
| Pacira BioSciences | 786.33M |
| Embecta | 785.32M |
| Avid Bioservices | 781.54M |
| Prothena Corporation | 774.85M |
| Pliant Therapeutics | 774.67M |
| Avanos Medical | 771.29M |